RELATED LINKS - XEINA DRUGS PRODUCT PORTFOLIO:
COVID Portfolio | Stem Cell Therapy | Finished Dosage Formulations | Biosimilars | Specialized Products | Facial Aesthetics
The coronavirus COVID-19 pandemic is the defining global health crisis of our time and the greatest challenge we have faced. Since its emergence in Asia in 2019, the virus has spread to every continent.
Xeina, with an aim to provide quick access to medicines and deliver quality products, has also diversified its offering to combat COVID-19 from its certified and trusted suppliers. We now offer products covering the three most essential modalities, which are:
- Prevention (various types of Masks, PPE kits)
- Testing Kits (Antibody and Antigen testing kits from Europe)
- Treatment (various pharmaceutical products used for treatment of COVID-19)